Literature DB >> 7800780

Social and legal factors related to drug abuse in the United States and Japan.

S B Greberman1, K Wada.   

Abstract

This article is an overview of social and legal differences in the United States and in Japan that are related to patterns of current drug abuse epidemics in these countries. These two nations have drug abuse problems with different histories and take different approaches currently to handling illicit drug marketing and use. Histories of opiate and cocaine abuse in the United States and of stimulant and inhalant abuse in Japan are discussed. The United States has experienced three heroin epidemics in the last three decades; cocaine addiction began to merit national concern by the end of the 1980s. In Japan, the first methamphetamine epidemic began after World War II; it was controlled in the 1950s. The current inhalant epidemic began in the late 1960s and was followed by the second methamphetamine epidemic that began in 1970; both are continuing to the present. The criminal justice system is always given first consideration when assessing societal measures employed to reduce drug use. Legal penalties for illicit drug offenses reflect the societal differences of these two nations with respect to the seriousness of particular types of crimes. Characteristics of the health care system of a nation may also influence patterns of drug abuse, particularly where functions of criminal justice and health care systems overlap. Health care systems in the United States and in Japan are based on different treatment philosophies and patients' expectations; these differences are discussed along with explanations of their potential influence on the epidemiology of drug abuse.

Entities:  

Mesh:

Year:  1994        PMID: 7800780      PMCID: PMC1403573     

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  17 in total

1.  Effects of legal restraint on the use of drugs: a review of empirical studies.

Authors:  R G Smart
Journal:  Bull Narc       Date:  1976 Jan-Mar

2.  Drug abuse and counter-measures in Japan.

Authors:  H Kumagai
Journal:  Med J Malaysia       Date:  1974-12

3.  Prevalence of volatile solvent inhalation among junior high school students in Japan and background life style of users.

Authors:  K Wada; S Fukui
Journal:  Addiction       Date:  1993-01       Impact factor: 6.526

4.  Relationship of consumers' perceptions of drugs to drug use.

Authors:  J L Grahn
Journal:  Public Health Rep       Date:  1983 Jan-Feb       Impact factor: 2.792

5.  A birds eye view of the present state of drug abuse in Japan.

Authors:  M Kato
Journal:  Drug Alcohol Depend       Date:  1983-02       Impact factor: 4.492

Review 6.  Mexican-American heroin addicts.

Authors:  D P Desmond; J F Maddux
Journal:  Am J Drug Alcohol Abuse       Date:  1984       Impact factor: 3.829

7.  Japan's high-cost illness insurance program: a study of its first three years, 1974-76.

Authors:  J H Broida; N Maeda
Journal:  Public Health Rep       Date:  1978 Mar-Apr       Impact factor: 2.792

8.  Opium availability and the prevalence of addiction in Asia.

Authors:  J Westermeyer
Journal:  Br J Addict       Date:  1981-03

9.  Over-the-counter drugs: factors in adult use of sedatives, tranquilizers, and stimulants.

Authors:  R Bell
Journal:  Public Health Rep       Date:  1984 May-Jun       Impact factor: 2.792

10.  Japan: stimulant epidemics past and present.

Authors:  M Tamura
Journal:  Bull Narc       Date:  1989
View more
  10 in total

1.  Culture, psychosomatics and substance abuse: the example of body image drugs.

Authors:  Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Psychother Psychosom       Date:  2012-01-18       Impact factor: 17.659

2.  Differential regulation of accumbal dopamine transmission in rats following cocaine, heroin and speedball self-administration.

Authors:  Lindsey P Pattison; Scot McIntosh; Evgeny A Budygin; Scott E Hemby
Journal:  J Neurochem       Date:  2012-05-23       Impact factor: 5.372

3.  Speedball induced changes in electrically stimulated dopamine overflow in rat nucleus accumbens.

Authors:  Lindsey P Pattison; Keith D Bonin; Scott E Hemby; Evgeny A Budygin
Journal:  Neuropharmacology       Date:  2010-09-24       Impact factor: 5.250

4.  Reduced carboxylesterase 1 is associated with endothelial injury in methamphetamine-induced pulmonary arterial hypertension.

Authors:  Mark E Orcholski; Artyom Khurshudyan; Elya A Shamskhou; Ke Yuan; Ian Y Chen; Sean D Kodani; Christophe Morisseau; Bruce D Hammock; Ellen M Hong; Ludmila Alexandrova; Tero-Pekka Alastalo; Gerald Berry; Roham T Zamanian; Vinicio A de Jesus Perez
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-05-04       Impact factor: 5.464

5.  Null mutation of c-fos causes exacerbation of methamphetamine-induced neurotoxicity.

Authors:  X Deng; B Ladenheim; L I Tsao; J L Cadet
Journal:  J Neurosci       Date:  1999-11-15       Impact factor: 6.167

Review 6.  Combination pharmacotherapies for stimulant use disorder: a review of clinical findings and recommendations for future research.

Authors:  William W Stoops; Craig R Rush
Journal:  Expert Rev Clin Pharmacol       Date:  2014-04-09       Impact factor: 5.045

Review 7.  Evaluation of the "Pipeline" for Development of Medications for Cocaine Use Disorder: A Review of Translational Preclinical, Human Laboratory, and Clinical Trial Research.

Authors:  Paul W Czoty; William W Stoops; Craig R Rush
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

Review 8.  Agonist replacement for stimulant dependence: a review of clinical research.

Authors:  William W Stoops; Craig R Rush
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

Review 9.  Brain Histamine N-Methyltransferase As a Possible Target of Treatment for Methamphetamine Overdose.

Authors:  Junichi Kitanaka; Nobue Kitanaka; F Scott Hall; George R Uhl; Motohiko Takemura
Journal:  Drug Target Insights       Date:  2016-03-02

10.  Ifenprodil for the treatment of methamphetamine use disorder: An exploratory, randomized, double-blind, placebo-controlled trial.

Authors:  Hiroko Kotajima-Murakami; Ayumi Takano; Shinya Hirakawa; Yasukazu Ogai; Daisuke Funada; Yuko Tanibuchi; Eriko Ban; Minako Kikuchi; Hisateru Tachimori; Kazushi Maruo; Takahiro Kawashima; Yui Tomo; Tsuyoshi Sasaki; Hideki Oi; Toshihiko Matsumoto; Kazutaka Ikeda
Journal:  Neuropsychopharmacol Rep       Date:  2022-01-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.